Current and new antitumor necrosis factor agents in perspective
Open Access
- 1 January 2004
- journal article
- review article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 6 (Suppl 2) , S1-S2
- https://doi.org/10.1186/ar994
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- How does infliximab work in rheumatoid arthritis?Arthritis Research & Therapy, 2002
- Clinical Significance of Cytokine Determination in Synovial FluidCritical Reviews in Clinical Laboratory Sciences, 2002
- Rheumatoid arthritisPublished by Elsevier ,2001
- Consensus recommendations for the assessment and treatment of rheumatoid arthritis.2001
- Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?Annual Review of Immunology, 2001
- Taming TNF: strategies to restrain this proinflammatory cytokineImmunology Today, 1997
- ROLE OF CYTOKINES IN RHEUMATOID ARTHRITISAnnual Review of Immunology, 1996
- Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritisThe Lancet, 1994
- Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor αArthritis & Rheumatism, 1993
- TNFα—A PIVOTAL ROLE IN RHEUMATOID ARTHRITIS?Rheumatology, 1992